301 related articles for article (PubMed ID: 29219225)
1. DCE-MRI texture analysis with tumor subregion partitioning for predicting Ki-67 status of estrogen receptor-positive breast cancers.
Fan M; Cheng H; Zhang P; Gao X; Zhang J; Shao G; Li L
J Magn Reson Imaging; 2018 Jul; 48(1):237-247. PubMed ID: 29219225
[TBL] [Abstract][Full Text] [Related]
2. Intratumor partitioning and texture analysis of dynamic contrast-enhanced (DCE)-MRI identifies relevant tumor subregions to predict pathological response of breast cancer to neoadjuvant chemotherapy.
Wu J; Gong G; Cui Y; Li R
J Magn Reson Imaging; 2016 Nov; 44(5):1107-1115. PubMed ID: 27080586
[TBL] [Abstract][Full Text] [Related]
3. Radiomic Analysis of Pharmacokinetic Heterogeneity Within Tumor Based on the Unsupervised Decomposition of Dynamic Contrast-Enhanced MRI for Predicting Histological Characteristics of Breast Cancer.
Zhang L; Fan M; Wang S; Xu M; Li L
J Magn Reson Imaging; 2022 Jun; 55(6):1636-1647. PubMed ID: 34773446
[TBL] [Abstract][Full Text] [Related]
4. Differences in tumour heterogeneity based on dynamic contrast-enhanced MRI between tumour and peritumoural stroma for predicting Ki-67 status of invasive ductal carcinoma.
He X; Zhou J; Ye S; Cheng Q; Miao H; Xu N; Li J; Pan Z; Cheng J; Wang M
Clin Radiol; 2021 Jun; 76(6):470.e13-470.e22. PubMed ID: 33648758
[TBL] [Abstract][Full Text] [Related]
5. Texture Analysis of Breast DCE-MRI Based on Intratumoral Subregions for Predicting HER2 2+ Status.
Lu H; Yin J
Front Oncol; 2020; 10():543. PubMed ID: 32373531
[No Abstract] [Full Text] [Related]
6. Role of dynamic contrast-enhanced MRI in evaluating the association between contralateral parenchymal enhancement and survival outcome in ER-positive, HER2-negative, node-negative invasive breast cancer.
Shin GW; Zhang Y; Kim MJ; Su MY; Kim EK; Moon HJ; Yoon JH; Park VY
J Magn Reson Imaging; 2018 Dec; 48(6):1678-1689. PubMed ID: 29734483
[TBL] [Abstract][Full Text] [Related]
7. Quantification of breast tumor heterogeneity for ER status, HER2 status, and TN molecular subtype evaluation on DCE-MRI.
Chang RF; Chen HH; Chang YC; Huang CS; Chen JH; Lo CM
Magn Reson Imaging; 2016 Jul; 34(6):809-819. PubMed ID: 26968141
[TBL] [Abstract][Full Text] [Related]
8. Diffusion Kurtosis at 3.0T as an in vivo Imaging Marker for Breast Cancer Characterization: Correlation With Prognostic Factors.
Huang Y; Lin Y; Hu W; Ma C; Lin W; Wang Z; Liang J; Ye W; Zhao J; Wu R
J Magn Reson Imaging; 2019 Mar; 49(3):845-856. PubMed ID: 30260589
[TBL] [Abstract][Full Text] [Related]
9. Preoperative prediction of lymphovascular invasion in invasive breast cancer with dynamic contrast-enhanced-MRI-based radiomics.
Liu Z; Feng B; Li C; Chen Y; Chen Q; Li X; Guan J; Chen X; Cui E; Li R; Li Z; Long W
J Magn Reson Imaging; 2019 Sep; 50(3):847-857. PubMed ID: 30773770
[TBL] [Abstract][Full Text] [Related]
10. Assessing the performance of benign and malignant breast lesion classification with bilateral TIC differentiation and other effective features in DCE-MRI.
Li H; Sun H; Liu S; Zhang W; Arukalam FM; Ma H; Qian W
J Magn Reson Imaging; 2019 Aug; 50(2):465-473. PubMed ID: 30688398
[TBL] [Abstract][Full Text] [Related]
11. Preoperative prediction of sentinel lymph node metastasis in breast cancer by radiomic signatures from dynamic contrast-enhanced MRI.
Liu C; Ding J; Spuhler K; Gao Y; Serrano Sosa M; Moriarty M; Hussain S; He X; Liang C; Huang C
J Magn Reson Imaging; 2019 Jan; 49(1):131-140. PubMed ID: 30171822
[TBL] [Abstract][Full Text] [Related]
12. Intratumoral and Peritumoral Radiomics Based on Functional Parametric Maps from Breast DCE-MRI for Prediction of HER-2 and Ki-67 Status.
Li C; Song L; Yin J
J Magn Reson Imaging; 2021 Sep; 54(3):703-714. PubMed ID: 33955619
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity in intratumoral regions with rapid gadolinium washout correlates with estrogen receptor status and nodal metastasis.
Chaudhury B; Zhou M; Goldgof DB; Hall LO; Gatenby RA; Gillies RJ; Patel BK; Weinfurtner RJ; Drukteinis JS
J Magn Reson Imaging; 2015 Nov; 42(5):1421-30. PubMed ID: 25884277
[TBL] [Abstract][Full Text] [Related]
14. Influence of temporal parameters of DCE-MRI on the quantification of heterogeneity in tumor vascularization.
Crombé A; Saut O; Guigui J; Italiano A; Buy X; Kind M
J Magn Reson Imaging; 2019 Dec; 50(6):1773-1788. PubMed ID: 30980697
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Dynamic Contrast-Enhanced MRI and Non-Mono-Exponential Model-Based Diffusion-Weighted Imaging for the Prediction of Prognostic Biomarkers and Molecular Subtypes of Breast Cancer Based on Radiomics.
Zhang L; Zhou XX; Liu L; Liu AY; Zhao WJ; Zhang HX; Zhu YM; Kuai ZX
J Magn Reson Imaging; 2023 Nov; 58(5):1590-1602. PubMed ID: 36661350
[TBL] [Abstract][Full Text] [Related]
16. Radiomic analysis of imaging heterogeneity in tumours and the surrounding parenchyma based on unsupervised decomposition of DCE-MRI for predicting molecular subtypes of breast cancer.
Fan M; Zhang P; Wang Y; Peng W; Wang S; Gao X; Xu M; Li L
Eur Radiol; 2019 Aug; 29(8):4456-4467. PubMed ID: 30617495
[TBL] [Abstract][Full Text] [Related]
17. Dynamic contrast-enhanced and diffusion-weighted MRI of estrogen receptor-positive invasive breast cancers: Associations between quantitative MR parameters and Ki-67 proliferation status.
Shin JK; Kim JY
J Magn Reson Imaging; 2017 Jan; 45(1):94-102. PubMed ID: 27313102
[TBL] [Abstract][Full Text] [Related]
18. Differentiating axillary lymph node metastasis in invasive breast cancer patients: A comparison of radiomic signatures from multiparametric breast MR sequences.
Chai R; Ma H; Xu M; Arefan D; Cui X; Liu Y; Zhang L; Wu S; Xu K
J Magn Reson Imaging; 2019 Oct; 50(4):1125-1132. PubMed ID: 30848041
[TBL] [Abstract][Full Text] [Related]
19. Enhancement parameters on dynamic contrast enhanced breast MRI: do they correlate with prognostic factors and subtypes of breast cancers?
Kim JY; Kim SH; Kim YJ; Kang BJ; An YY; Lee AW; Song BJ; Park YS; Lee HB
Magn Reson Imaging; 2015 Jan; 33(1):72-80. PubMed ID: 25179138
[TBL] [Abstract][Full Text] [Related]
20. Identifying relations between imaging phenotypes and molecular subtypes of breast cancer: Model discovery and external validation.
Wu J; Sun X; Wang J; Cui Y; Kato F; Shirato H; Ikeda DM; Li R
J Magn Reson Imaging; 2017 Oct; 46(4):1017-1027. PubMed ID: 28177554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
